Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ReplyCorrespondence

Dr. Fitzcharles, et al, reply

MARY-ANN FITZCHARLES, PETER A. STE-MARIE, EMMANOUIL RAMPAKAKIS, JOHN S. SAMPALIS and YORAM SHIR
The Journal of Rheumatology November 2016, 43 (11) 2077; DOI: https://doi.org/10.3899/jrheum.160991
MARY-ANN FITZCHARLES
Alan Edwards Pain Management Unit, and Division of Rheumatology, McGill University Health Centre, Montreal;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mary-ann.fitzcharles@muhc.mcgill.ca
PETER A. STE-MARIE
Alan Edwards Pain Management Unit, McGill University Health Centre;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMMANOUIL RAMPAKAKIS
JSS Medical Research, St-Laurent, and Jewish General Hospital, McGill University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN S. SAMPALIS
JSS Medical Research, St-Laurent, and Jewish General Hospital, McGill University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YORAM SHIR
Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

We appreciate the comments of Drs. Ferrari and Russell1 regarding our study that examined factors associated with disability in persons with fibromyalgia (FM)2. We observed that 31% of patients with FM in our cohort of 248 patients were disabled and receiving disability payments for FM. The disabled patients with FM were more symptomatic, used more medications, and were more likely to have previously worked in physically demanding jobs. Drs. Ferrari and Russell raise the issue of symptom exaggeration by some persons with FM as a means of obtaining disability payments and suggest that effort testing and symptom exaggeration testing should be an essential component in evaluation of disability due to FM.

We agree that the extremely high rate of disability due to FM is worrisome, and that it is likely that there are some persons with FM who may be exaggerating subjective symptoms for reasons of secondary gain. We also acknowledge that the physician assessment of the severity of subjective complaint is fraught with challenges, requiring the physician to both record the complaint as presented by the patient, and also to assess the validity of the symptom report. Effort testing cannot, however, at this time be applied as a universal tool to validate symptom severity in FM, or be used as a measurement to adjudicate disability. Measurement of effort in this setting is being used as a surrogate for symptom severity, an association that has not been demonstrated to date. The critical question in the evaluation of subjective complaints as a reason for disability remains the severity of symptoms, which in turn affects functional status. A full clinical evaluation that includes assessment of day-to-day activities, information from all treating healthcare professionals, and careful observation during assessment for evidence of discrepancies in clinical findings should still remain the standard by which functionality is assessed, rather than failure on a memory effort test3.

It is also possible that some patients seeking disability status or currently identified as disabled need to maintain an illness role and thus cannot afford to get better. We agree that motivation toward health or alternatively toward disability likely contributes to symptom perception by the patient, and those who have been in a prolonged vortex of illness will lose motivation to return to health. Alternatively, returning to a work environment that is less satisfactory and enjoyable may preclude efforts toward health.

It is innate that physicians should be empathetic and trust the veracity of a patient report. We would therefore caution against a global mistrust toward patients with FM, especially because the condition to date still defies our understanding. Physicians should not compromise care of the many persons with FM as a result of the likely few who abuse the system. Rather than stating that, according to Ferrari and Russell, “FM is an illness characterized in part by a lack of face validity,” we contend that suggesting that “effort testing and symptom exaggeration testing are essential in assessing patients with FM presenting for disability-related evaluations” truly lacks face validity.

REFERENCES

  1. 1.↵
    1. Ferrari R,
    2. Russell AS
    . Effort testing and symptom exaggeration testing essential in assessing patients with fibromyalgia for disability. J Rheumatol 2016;43:2077.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Fitzcharles MA,
    2. Ste-Marie PA,
    3. Rampakakis E,
    4. Sampalis JS,
    5. Shir Y
    . Disability in fibromyalgia associates with symptom severity and occupation characteristics. J Rheumatol 2016;43:931–6.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Gervais RO,
    2. Russell AS,
    3. Green P,
    4. Allen LM 3rd,
    5. Ferrari R,
    6. Pieschl SD
    . Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol 2001;28:1892–9.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 43, Issue 11
1 Nov 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dr. Fitzcharles, et al, reply
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dr. Fitzcharles, et al, reply
MARY-ANN FITZCHARLES, PETER A. STE-MARIE, EMMANOUIL RAMPAKAKIS, JOHN S. SAMPALIS, YORAM SHIR
The Journal of Rheumatology Nov 2016, 43 (11) 2077; DOI: 10.3899/jrheum.160991

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Dr. Fitzcharles, et al, reply
MARY-ANN FITZCHARLES, PETER A. STE-MARIE, EMMANOUIL RAMPAKAKIS, JOHN S. SAMPALIS, YORAM SHIR
The Journal of Rheumatology Nov 2016, 43 (11) 2077; DOI: 10.3899/jrheum.160991
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Dr. Sehgal et al reply
  • Dr. Sugawara et al reply
  • Dr. Kremer et al reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire